Report: The Millenium Development Goals 2011

Click here for full report

The United Nations (UN) released a report on July 12 on the progress made thus far on the 8 Millennium Development Goals (MDGs). The eight MDGs include: end poverty and hunger, universal education, gender equality, child health, maternal health, combat HIV/AIDS, environmental sustainability, and global partnership. To learn more about the MDGs, go to Key highlights of the report are:

Positive Impacts

  • Targeted interventions have succeeded in reducing child mortality
  • Increased funding and control efforts have cut deaths from malaria
  • Investments in preventing and treating HIV are yielding results
  • Effective strategies against tuberculosis are saving millions of lives
  • Effective strategies against tuberculosis are saving millions of lives
  • Poverty continues to decline in many countries and regions
  • Some of the poorest countries have made the greatest strides in education

Areas lagging behind

  • The poorest children have made the slowest progress in terms of improved nutrition
  • Opportunities for full and productive employment remain particularly slim for women
  • Being poor, female or living in a conflict zone increases the probability that a child will be out of school
  • Advances in sanitation often bypass the poor and those living in rural areas
  • Improving the lives of a growing number of urban poor remains a monumental challenge
  • Progress has been uneven in improving access to safe drinking water

Additional coverage: UN report paints mixed picture of global progress on MDG goals

More News
17 Sep 2019
Earlier this month, the NIH announced two new Funding Opportunity Annoucnements (FOAs) on the topic of Myeloid-Derived Suppressor Cells (MDSC) as potential therapeutic targets in TB/HIV co-infected patients. The purpose of these FOAs is to invite applications for support of innovative clinical,...
14 Aug 2019
FDA released the following press release on Wednesday, August 14th: The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. “The threat of...
27 Jun 2019
-- Globe Newswire reported on June 20th -- Spero Therapeutics, Inc. , a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, today...